# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Gainers
The month of October marks a slowdown in SPAC merger deal votes, but the calendar does include several multibillion-dollar deal...
Northland Capital Markets analyst Tim Chiang initiates coverage on Big Cypress Acquisition (NASDAQ:BCYP) with a Outperform r...
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifi...
Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on Big Cypress Acquisition (NASDAQ:BCYP) with a Buy rating and a...
$200 million total awarded to date for DiversitAb™ Rapid Response Antibody Program including Stage 4 COVID-19 Pandemic Respo...